PHAR - Pharming Group NV - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PHAR is currently covered by 2 analysts with an average price target of $34.74. This is a potential upside of $24.64 (243.96%) from yesterday's end of day stock price of $10.1.

Pharming Group NV's activity chart (see below) currently has 5 price targets and 14 ratings on display. The stock rating distribution of PHAR is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for PHAR is $37, Lowest price target is $30, average price target is $33.5.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 16-Dec-2024. First documented stock forecast 16-Feb-2023.

Best performing analysts who are covering PHAR - Pharming Group NV:

Joseph Pantginis Michael Carrier

Currently out of the existing stock ratings of PHAR, 10 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$37

$26.75 (260.98%)

$37

7 months 7 days ago
(16-Dec-2024)

0/12 (0%)

$28.11 (316.20%)

Buy

$30

$19.75 (192.68%)

$40

8 months 25 days ago
(28-Oct-2024)

0/2 (0%)

$21.16 (239.37%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PHAR (Pharming Group NV) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on PHAR (Pharming Group NV) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the current lower performing score on PHAR (Pharming Group NV) with a proven track record?

MICHAEL CARRIER

Which analyst has the most public recommendations on PHAR (Pharming Group NV)?

Joseph Pantginis has 32 price targets and 24 ratings on PHAR

Which analyst is the currently most bullish on PHAR (Pharming Group NV)?

Joseph Pantginis with highest potential upside - $26.75

Which analyst is the currently most reserved on PHAR (Pharming Group NV)?

Michael Carrier with lowest potential downside - $19.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?